OPC Pharmaceutical JSC (HOSE:OPC)

Market Cap	1.51T
Revenue (ttm)	1.13T +17.8%
Net Income	95.36B +12.5%
EPS	1,488.88 +6.7%
Shares Out	64.05M
PE Ratio	15.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	716
Average Volume	101,890
Open	23,500
Previous Close	23,500
Day's Range	23,500 - 24,900
52-Week Range	21,100 - 25,400
Beta	0.12
RSI	53.71
Earnings Date	Jul 28, 2026

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In additi...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 871
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: OPC

Financial Performance

In 2025, OPC Pharmaceutical JSC's revenue was 1.12 trillion, an increase of 15.94% compared to the previous year's 968.58 billion. Earnings were 98.50 billion, an increase of 4.33%.